Remission of Alopecia Universalis in a Patient with Atopic Dermatitis Treated with Dupilumab
Atopic Dermatitis (AD), a type of eczema, is an inflammatory skin disorder that causes redness, itching and dryness. It has been associated
Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata
We are so excited to announce that yesterday the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for CoNCERT Pharmaceuticals'
Understanding the Risks of JAK Inhibitors
For several years now Janus Kinase (JAK) inhibitors have been the latest breakthrough in Alopecia Areata treatment. Rather than suppressing the entire